Opening book details…
About this Medicine article
WS19.2 Long-term safety of lumacaftor/ivacaftor therapy in persons with cystic fibrosis aged 2–5 years homozygous for the F508del-CFTR mutation (F/F) by Hoppe, J.; Chilvers, M.; Ratjen, F.; McNamara, J.J.; Owen, C.A.; Tian, S.; Zahigian, R.; Cornell, A.G.; McColley, S.A. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Hoppe, J.; Chilvers, M.; Ratjen, F.; McNamara, J.J.; Owen, C.A.; Tian, S.; Zahigian, R.; Cornell, A.G.; McColley, S.A.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 1569-1993)
- Published
- 2020
- Field
- Medicine (Health Sciences)